Group NewsLocation: Home(英) / News / Group News / Content

Wang Yuhang, General Manager of CAMCE accompanied Zhang Xiaolun, Chairman of SINOMACH to visit the State Administration of Traditional Chinese Medicine

By: From: Posted: 2020-05-18 15:12:00 FontSize: BIG MIDDLE SMALL

  On the afternoon of May 13, 2020, in order to implement the important instruction of General Secretary Xi Jinping's Promoting the Industrialization and Modernization of Traditional Chinese Medicine and Letting Traditional Chinese Medicine Go to the World, Zhang Xiaolun, Chairman of SINOMACH led a team to visit the State Administration of Traditional Chinese Medicine(SATCM). He held talks with Yu Wenming, Director of SATCM, and Sun Da, Deputy Director of SATCM. Bai Shaotong, Deputy General Manager of SINOMACH, Sun Miao, Secretary of the Board of Directors and Office of SINOMACH, Luo Yan, Marketing Director of SINOMACH, and Wang Yuhang, General Manager of CAMCE attended the meeting. All parties conducted in-depth exchanges on the development of international cooperation and mutually beneficial development of Chinese medicine.

  Zhang Xiaolun said that under the guidance of SATCM, SINOMACH will strengthen cooperation with SINOPHARM Group and jointly play the main role of central enterprises on Chinese traditional medicine equipment production, high-end   instruments manufacturing and industrialization of medical devices. Both parties will make full use of their own advantages and make contributions to the internationalization of Chinese traditional medicine.

  Zhang Xiaolun introduced that since the outbreak of the COVID-19, SINOMACH has carefully implemented a series of major decision-making arrangements of the Party Central Committee, effectively integrated internal resources, actively changed the line of production and expanded production. SINOMACH effectively paid special attention to the prevention and control of the company's overseas epidemic situation, and made outstanding contributions to winning the fight of epidemic prevention and control while successfully completing the task of guaranteeing supply and orderly advancing comprehensive resumption of production.

  Zhang Xiaolun mentioned in particular that SINOMACH has unique advantages in hospital design and management, including industry planning, plant construction, logistics system design and development, and warehousing and packaging. SINOMACH also has obvious advantages in the R&D and manufacturing of agricultural machinery. Over the years, SINOMACH has actively implemented the Going Global strategy, established branches in more than 100 countries and regions around the world, and implemented a large number of model international engineering projects.

  Zeng Bing, Deputy General Manager of SINOPHARM Group, said that SINOPHARM Group will take advantage of its professional advantages in Chinese herbal medicine repurchase, hospital operation, medical equipment integration and other fields, and actively cooperate with SINOMACH to promote the overseas development of the Chinese traditional medicine industry chain.

  Yu Wenming praised SINOMACH's achievements in international operation and epidemic prevention and control, and expressed that SATCM would learn from the development and construction model of the China-Belarus Industrial Park project, strengthen cooperation with local governments, and support SINOMACH and SINOPHARM to actively participate in the state Belt and Road internationalization of Chinese traditional medicine.

  The head of the Strategic Investment Department of SINOMACH attended the meeting.

Add to FavoritesPrint
XML 地图 | Sitemap 地图